These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31499390)

  • 41. Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice.
    Ahrén B; Simonsson E; Scheurink AJ; Mulder H; Myrsén U; Sundler F
    Metabolism; 1997 Jan; 46(1):97-106. PubMed ID: 9005977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat.
    Smith GC; Chaussade C; Vickers M; Jensen J; Shepherd PR
    Diabetologia; 2008 Dec; 51(12):2309-17. PubMed ID: 18843478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Meal-induced insulin sensitization is preserved after acute olanzapine administration in female Sprague-Dawley rats.
    Kovács D; Hegedűs C; Kiss R; Sári R; Németh J; Szilvássy Z; Peitl B
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):525-30. PubMed ID: 25644372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice.
    O'Harte FP; Ng MT; Lynch AM; Conlon JM; Flatt PR
    Diabetes Obes Metab; 2016 Oct; 18(10):1013-24. PubMed ID: 27357054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of acute olanzapine exposure on central insulin-mediated regulation of whole body fuel selection and feeding.
    Castellani LN; Wilkin J; Abela AR; Benarroch L; Ahasan Z; Teo C; Wilson V; Kowalchuk C; Giacca A; Remington GJ; Hahn MK
    Psychoneuroendocrinology; 2018 Dec; 98():127-130. PubMed ID: 30142549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The IRS/PI3K/Akt signaling pathway mediates olanzapine-induced hepatic insulin resistance in male rats.
    Ren L; Zhou X; Huang X; Wang C; Li Y
    Life Sci; 2019 Jan; 217():229-236. PubMed ID: 30550886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention Effects and Possible Molecular Mechanism of Mulberry Leaf Extract and its Formulation on Rats with Insulin-Insensitivity.
    Liu Y; Li X; Xie C; Luo X; Bao Y; Wu B; Hu Y; Zhong Z; Liu C; Li M
    PLoS One; 2016; 11(4):e0152728. PubMed ID: 27054886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isoproterenol exacerbates hyperglycemia and modulates chromium distribution in mice fed with a high fat diet.
    Chang GR; Chen WK; Hou PH; Mao FC
    J Trace Elem Med Biol; 2017 Dec; 44():315-321. PubMed ID: 28965593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin Resistance-Related Proteins Are Overexpressed in Patients and Rats Treated With Olanzapine and Are Reverted by Pueraria in the Rat Model.
    Yang N; Li S; Liu S; Lv Y; Yu L; Deng Y; Li H; Fang M; Huo Y; Li W; Peng S
    J Clin Psychopharmacol; 2019; 39(3):214-219. PubMed ID: 30946280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medium-chain triglyceride ameliorates insulin resistance and inflammation in high fat diet-induced obese mice.
    Geng S; Zhu W; Xie C; Li X; Wu J; Liang Z; Xie W; Zhu J; Huang C; Zhu M; Wu R; Zhong C
    Eur J Nutr; 2016 Apr; 55(3):931-40. PubMed ID: 25911003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toxicity manifestations and sex differences due to MARTA olanzapine.
    Hattori-Usami N; Kaizaki-Mitsumoto A; Ashino T; Yamamoto M; Numazawa S
    J Toxicol Sci; 2023; 48(4):191-202. PubMed ID: 37005277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic and endocrinal effects of N-desmethyl-olanzapine in mice with obesity: Implication for olanzapine-associated metabolic changes.
    Zhang X; Zhao Y; Shao H; Zheng X
    Psychoneuroendocrinology; 2019 Oct; 108():163-171. PubMed ID: 31302499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ameliorative effect of vanadyl(IV)-ascorbate complex on high-fat high-sucrose diet-induced hyperglycemia, insulin resistance, and oxidative stress in mice.
    Liu Y; Xu J; Guo Y; Xue Y; Wang J; Xue C
    J Trace Elem Med Biol; 2015 Oct; 32():155-61. PubMed ID: 26302923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrophage migration inhibitory factor mediates metabolic dysfunction induced by atypical antipsychotic therapy.
    Cui D; Peng Y; Zhang C; Li Z; Su Y; Qi Y; Xing M; Li J; Kim GE; Su KN; Xu J; Wang M; Ding W; Piecychna M; Leng L; Hirasawa M; Jiang K; Young L; Xu Y; Qi D; Bucala R
    J Clin Invest; 2018 Nov; 128(11):4997-5007. PubMed ID: 30295645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of the adverse effects of olanzapine on lipid metabolism with the antiepileptic zonisamide.
    Stefanidis A; Watt MJ; Cowley MA; Oldfield BJ
    Neuropharmacology; 2017 Sep; 123():55-66. PubMed ID: 28400260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased Insulin Resistance and Glucagon Levels in Mild/Inactive Systemic Lupus Erythematosus Patients Despite Normal Glucose Tolerance.
    Miyake CNH; Gualano B; Dantas WS; Pereira RT; Neves W; Zambelli VO; Shinjo SK; Pereira RM; Silva ER; Sá-Pinto AL; Borba E; Roschel H; Bonfá E; Benatti FB
    Arthritis Care Res (Hoboken); 2018 Jan; 70(1):114-124. PubMed ID: 28320046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in alpha2A-adrenoceptor knockout mice.
    Savontaus E; Fagerholm V; Rahkonen O; Scheinin M
    Eur J Pharmacol; 2008 Jan; 578(2-3):359-64. PubMed ID: 17964569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fetal hyperglycemia acutely induces persistent insulin resistance in skeletal muscle.
    Kua KL; Hu S; Wang C; Yao J; Dang D; Sawatzke AB; Segar JL; Wang K; Norris AW
    J Endocrinol; 2019 Jul; 242(1):M1-M15. PubMed ID: 30444716
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
    Karwi QG; Zhang L; Wagg CS; Wang W; Ghandi M; Thai D; Yan H; Ussher JR; Oudit GY; Lopaschuk GD
    Cardiovasc Diabetol; 2019 Jan; 18(1):1. PubMed ID: 30626440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.